TG Therapeutics | TGTX - Loan Capital


TG Therapeutics reported $245.34M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Amgen USD 50B 2.43B Dec/2025
Ardelyx USD 202.14M 27.07M Sep/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
Bayer EUR 32.71B 1B Sep/2025
Biogen USD 6.29B 1.4M Sep/2025
Curis USD 29.43M 10.69M Jun/2024
Gilead Sciences USD 22.14B 5M Sep/2025
Infinity Pharmaceuticals USD 0 0 Jun/2022
J&J USD 39.44B 30M Dec/2025
Karyopharm Therapeutics USD -0.93 0.67 Dec/2024
Novartis USD 24.24B 174M Sep/2025
Novavax USD 223.63M 187K Sep/2024
PTC Therapeutics USD 2.03B 193.22M Dec/2025
Puma Biotechnology USD 10.87M 222K Jun/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
TG Therapeutics USD 245.34M 303K Sep/2025
Verastem USD 50.32M 10.23M Mar/2024
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025